3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
-4.2812 -0.1233 0.2255 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6162 0.4053 0.0968 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5174 -0.6582 -0.4271 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9816 0.2830 -1.0694 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8647 -0.9614 0.9908 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2384 0.2813 0.0998 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2702 1.5337 0.7442 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4721 -0.6980 -0.3162 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1269 -0.5294 -0.2706 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6453 0.1401 -1.1883 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5320 -1.0661 0.8088 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5184 -0.2840 0.0278 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4181 1.6769 0.2779 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7589 1.1322 0.6198 H 0 0 0 0 0 0 0 0 0 0 0 0
4.4219 1.3202 1.8069 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6664 2.4430 0.6548 H 0 0 0 0 0 0 0 0 0 0 0 0
5.2432 1.7446 0.2884 H 0 0 0 0 0 0 0 0 0 0 0 0
5.4823 -0.3536 -0.5612 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0723 -1.1910 -1.2085 H 0 0 0 0 0 0 0 0 0 0 0 0
4.5456 -1.4369 0.4880 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2127 0.5966 -2.0727 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.0052 -1.6123 1.5844 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.4601 1.9539 0.4591 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.1041 2.1172 -0.6724 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8045 2.0849 1.0860 H 0 0 0 0 0 0 0 0 0 0 0 0
1 12 1 0 0 0 0
1 13 1 0 0 0 0
2 6 1 0 0 0 0
2 7 1 0 0 0 0
2 8 1 0 0 0 0
3 6 2 0 0 0 0
3 9 1 0 0 0 0
4 10 2 0 0 0 0
4 12 1 0 0 0 0
5 11 1 0 0 0 0
5 12 2 0 0 0 0
6 14 1 0 0 0 0
7 15 1 0 0 0 0
7 16 1 0 0 0 0
7 17 1 0 0 0 0
8 18 1 0 0 0 0
8 19 1 0 0 0 0
8 20 1 0 0 0 0
9 10 1 0 0 0 0
9 11 2 0 0 0 0
10 21 1 0 0 0 0
11 22 1 0 0 0 0
13 23 1 0 0 0 0
13 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
N,N-dimethyl-N'-(2-methylsulfanylpyrimidin-5-yl)methanimidamide
4.2 InChl
InChI=1S/C8H12N4S/c1-12(2)6-11-7-4-9-8(13-3)10-5-7/h4-6H,1-3H3
4.3 InChlKey
MDKISTZNRFJSFI-UHFFFAOYSA-N
4.4 Canonical SMILES
CN(C)C=NC1=CN=C(N=C1)SC
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病